Objective: To report a case of giant cell tumor (GCT) in conjunction with an aneurysmal bone cyst (ABC) in the lumbar spine (L4) of a young with post-treatment recovery. Introduction: Giant cell tumor ...

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act as guardians, keeping the lungs healthy, supporting breathing, and ...

1 Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China Giant Cell ...

The GCAptAIN study, which included patients with newly diagnosed or relapsing GCA, missed its primary endpoint of sustained remission at week 52. Topline results were announced from a phase 3 study ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of ...

Saudi Arabia’s NEOM Green Hydrogen Project is 80% complete, on track to start green ammonia exports by 2027. Despite global headwinds for hydrogen projects, including high costs and few offtake deals, ...

Neutrophil-to-lymphocyte ratio as a clinical biomarker for immune checkpoint inhibitor response in advanced sarcoma. IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with ...

Findings showed 46.4% of patients treated with upadacitinib 15 mg achieved sustained remission compared with 29.0% of those who received placebo. The Food and Drug Administration (FDA) has approved ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved upadacitinib to treat adults with giant cell arteritis. It is the second drug to be ...